Sort
130,381 grants matching “hiv”
DRIVE (DRug use and blood-borne Infections in ViEtnam): Combined prevention and care to end the HIV epidemic among people who inject drugs in Haiphong, Viet Nam
$978,594Don C Des Jarlais · New York University · R01 · FY2019 · DA
CENTER FOR METABOLIC RESEARCH ON HIV AND DRUG USE
$978,519Tufts University Boston · P30 · FY2003 · DA
Linkage of Alcohol Abusers to Primary Care
$978,427Richard Saitz · Boston Medical Center · R01 · FY2006 · AA
SAIA-PrEP: a systems analysis and improvement approach to optimize PrEP implementation in syringe service programs
$978,395Angela Robertson Bazzi · University Of California, San Diego · R01 · FY2023 · DA
Reversal of HIV latency in vivo
$978,330Steven Grant Deeks · University Of California, San Francisco · U19 · FY2014 · AI
Identification of Gene Polymorphisms Associated with Infectious Diseases
$978,326Cheryl Winkler · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Genetics of Renal Disease in African Americans
$978,326Cheryl Winkler · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
High Risk Drug Use & HIV-Learning from the NYC Epidemic
$978,265Sherry Deren · National Development And Research Institutes, Inc. · P30 · FY2006 · DA
Modeling Combination Immunotherapy for HIV Cure in Humanized Mouse Models
$978,174James L Riley · University Of Pennsylvania · U19 · FY2021 · AI
DEVELOPMENT OF A PRIMATE GENOMIC RESOURCE
$978,086Michael G Katze · University Of Washington · R24 · FY2009 · RR
Modeling Combination Immunotherapy for HIV Cure in Humanized Mouse Models
$978,042James L Riley · University Of Pennsylvania · U19 · FY2023 · AI
Preclinical development of a tenofovir intravaginal ring for HIV prophylaxis
$978,004Thomas J. Smith · Auritec Pharmaceuticals, Inc. · R44 · FY2012 · AI
DCTD Animal Support
$978,000Larry Arthur · Leidos Biomedical Research, Inc. · N01 · FY2010 · CA
HIV PREVENTION TRIAL FOR AT-RISK YOUNG PEOPLE IN RUSSIA
$977,988Medical College Of Wisconsin · U10 · FY2001 · MH
Retrovirus Evolution and Cancer
$977,972John M Coffin · Tufts University Boston · R35 · FY2017 · CA
Immune checkpoint inhibitors and accelerated coronary atherosclerosis
$977,964Tomas G Neilan · Massachusetts General Hospital · R01 · FY2023 · HL
Novel Diagnostic Sequencing System for HIV Resistance Testing
$977,698Jerzy Olejnik · Intelligent Bio-Systems, Inc. · R44 · FY2013 · AI
Gene Therapy for SCID-X1 using a self-inactivating (SIN) gammaretroviral vector
$977,629David A Williams · Boston Children'S Hospital · U01 · FY2012 · AI
Integrating ENGagement and Adherence Goals Upon Entry iENGAGE to Control HIV
$977,502Michael J Mugavero · University Of Alabama At Birmingham · R01 · FY2015 · AI
Optogenetics and Transgenic Technology Core
$977,493Brandon Harvey · National Institute On Drug Abuse · ZIC · FY2011 · DA
Acceptable Multi-user Biodegradable Extended Release (AMBER) Implant System for HIV Prevention
$977,476Leah Johnson · Research Triangle Institute · R01 · FY2021 · AI
Coordinating Center for the Pediatric HIV/AIDS Cohort Study II
$977,455Russell Barrett Van Dyke · Tulane University Of Louisiana · U01 · FY2012 · HD
SOUTHERN CALIFORNIA AIDS MALIGNANCY NETWORK
$977,442University Of California Los Angeles · U01 · FY2001 · CA
Harvard Medical School Vaccine Clinical Trials Unit
$977,281Raphael Dolin · Harvard Medical School · U01 · FY2008 · AI
St. Jude/Memphis IMPAACT Clinical Trials Unit
$977,266Patricia Michele Flynn · St. Jude Children'S Research Hospital · U01 · FY2008 · AI